2015
DOI: 10.1016/j.ymben.2014.11.001
|View full text |Cite
|
Sign up to set email alerts
|

Potential production platform of n-butanol in Escherichia coli

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
80
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(80 citation statements)
references
References 32 publications
(40 reference statements)
0
80
0
Order By: Relevance
“…A separate study adjusted the intracellular redox state by targeting central carbon metabolism to push flux of carbon through the pentose phosphate pathway (Saini et al, 2016). Additionally, other strains were engineered to produce 1-butanol from butanoate (Saini et al, 2015). 1-Butanol titers from E. coli and Clostridium species are comparable.…”
Section: Discussionmentioning
confidence: 99%
“…A separate study adjusted the intracellular redox state by targeting central carbon metabolism to push flux of carbon through the pentose phosphate pathway (Saini et al, 2016). Additionally, other strains were engineered to produce 1-butanol from butanoate (Saini et al, 2015). 1-Butanol titers from E. coli and Clostridium species are comparable.…”
Section: Discussionmentioning
confidence: 99%
“…However, previous research on microbial consortia was primarily concerned with the study of mixed population stability and dynamic interactions (7)(8)(9)(10)(11), although a few recent studies have reported the engineering of microbial consortia for utilization of simple sugars to make small molecules of central carbon metabolism, such as ethanol and lactate (12,13). Progress was made recently, when a full n-butanol pathway was expressed in two separate E. coli cells to achieve higher production (14) and when a bacterium-yeast coculture was used to address the difficulties of functional reconstitution of a pathway involving prokaryotic and eukaryotic enzymes in a consortium, and thus improved production of complex pharmaceutical molecules (15). Here, we expand the generality of the coculture engineering by demonstrating that microbial cocultures can also be engineered to overcome more universal challenges in metabolic engineering, including high-level intermediate secretion and low-efficiency sugar mixture utilization.…”
Section: -Hydroxybenzoic Acidmentioning
confidence: 99%
“…While the native producer Clostridium remains as the major workhorse for the production of 1-butanol on the industrial scale [38], engineering and characterization of the clostridial CoA-dependent pathway in various heterologous hosts have been extensively performed to decipher pathway bottleneck and address its limitation in recombinant systems [913]. Production titer and industrial practicality of heterologous 1-butanol synthesis have been significantly improved by many metabolic engineering approaches, such as replacement of inefficient enzymes [13, 14], creation of synthetic driving forces [15, 16], development of co-culturing system [17], utilization of inducer-free promoter [1820], and analysis of system-level pathway inefficiency [18, 20, 21], reaching the highest productivity of 5–6 g/L/d so far using Escherichia coli in bench-scale flasks. In addition to the CoA-dependent pathway, other synthetic pathways based on amino acid biosynthesis [22] and reverse β-oxidation [23] were also explored as the alternative 1-butanol production system.…”
Section: Introductionmentioning
confidence: 99%